Results · Apr-Jun 2026 · filed 5 Aug 2026
Godavari Biorefineries Q1 FY27 results
Sales grew 5% to ₹558 crore from ₹533 crore in Apr-Jun 2025.
Operating profit fell 91% to ₹0.52 crore, an operating margin of 0.1% (down 1.0 points from a year ago).
The net loss widened to ₹19.3 crore from ₹16 crore.
Against Jan-Mar 2026: sales −1%, swings to a loss.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 557.9 | 533.2 | +5% |
| Operating profit (EBITDA) | 0.5 | 5.8 | −91% |
| Operating margin | 0.1% | 1.1% | −1.0 pts |
| Net profit | -19.3 | -16.0 | loss widens |
Consolidated figures. Margins & ratios change in percentage points (pts).
The earnings call
Apr–Jun 2026 saw 4.9% total income growth. Bio-based chemicals surged 19.4% in revenue & 53% in EBITDA, but sugar-ethanol segment lost ₹14.6 crore. Management commissioned a 200 KLPD grain distillery, plans ₹25 crore chemical debottlenecking & expects preliminary cancer drug trials in Q3.
The last 7 quarters
Filings that week
- 11 Aug 2026Announcement Under Regulation 30- Patent
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 5 Aug 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release
- 5 Aug 2026Unaudited Financial Results For The Quarter Ended 30Th June, 2026
- 5 Aug 2026Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended 30Th June, 2026
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.